News Reduction of share capital Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Related Continue Reading Previous FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary FibrosisNext Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss Related Stories News Global Medical Devices Manufacturer Selects Kneat to Digitize Validation News Helport AI Launches on Google Cloud Marketplace, Redefining Intelligent Solutions for Global Businesses News Tomarket Launches First FarmingPool in Telegram Ecosystem to Unlock Early Rewards For Users News Zhibao Technology Inc Announces Financial Results for the Fiscal Year Ended June 30, 2024 News Right Wing Naturals Achieves Million-Dollar Revenue Milestone News Verizon and the East Side Mosquito Abatement District utilize technology to fight mosquitoes
